Arkolith/Insider Trading/FBIO/Form 4

Rosenwald Lindsay A MD

President, CEO & Chairman, Director, 10% OwnerFortress Biotech, Inc. (FBIO) · full profile →Form 4 · filed Jan 4, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 1, 2023Grant(A)1.2M—$013.0M
Jun 1, 2022Grant(A)4K$0.73$3K11.7M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-001103) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML